Back to Authors

Mina, Jonathan

https://orcid.org/0000-0001-8995-4385

Mayo Clinic

Cleveland Clinic

Citations 3

Pain Management in Autosomal Dominant Polycystic Kidney Disease
Borghol, Abdul Hamid , Debeh, Fadi George Munairdjy , Ghanem, Ahmad , Antoun, Mikhail D., Rangarajan, Vineetha, Mina, Jonathan , Hassanein, Mohamed , Baker, Lyle W. , Gupta, Sahil , Mao, Shennen A. , Munairdjy Debeh, Fadi George , Bou Antoun, Marie Therese , Hunt, Christine , Hogan, Marie C , Mao, Michael A , Chebib, Fouad T , Baker, Lyle Wesley , Mao, Shennen A , Rangarajan, Vineetha, Hogan, Marie C. , Mao, Michael A. , Chebib, Fouad T.

Kidney360 | July 7, 2025 | Volume: 6 | Issue: 9 | Pages: 1618-1631

10.34067/kid.0000000907 Get It

Autosomal dominant polycystic kidney disease (ADPKD) is the most common genetic kidney disorder. It is primarily caused by pathogenic variants in the PKD1 or PKD2 genes. This leads to the development of numerous kidney cysts, which can result in kidney enlargement and progression to kidney failure. Pain is a common symptom in ADPKD and can negatively affect quality of life (QOL). This pain is often due to the continuous growth of kidney and liver cysts or associated cystic complications. We present a case of a 29-year-old woman with ADPKD who experienced chronic, refractory right-sided flank pain that significantly affected her QOL. Her pain persisted despite taking daily multimodal analgesics and undergoing multiple invasive interventions. She had an unusual asymmetric disease with the right kidney accounting for only 24% of her kidney function. After exhausting all other pain control strategies, she underwent right nephrectomy and partial hepatectomy, which led to substantial improvement in pain and QOL. This review describes the causes, manifestations, and management strategies for abdominal and/or flank pain in ADPKD, including a practical stepwise algorithm to guide clinicians in managing pain and improve QOL of patients with ADPKD. Pain in ADPKD can either be acute or chronic and can lead to significant physical and psychologic distress. Effective pain management in ADPKD requires a multidisciplinary approach, incorporating both nonpharmacologic and pharmacologic interventions such as gabapentin or tolvaptan in select cases. Interventions considered in ADPKD pain control include cyst aspiration with sclerotherapy, celiac plexus blockade, spinal cord stimulation, renal denervation, or nephrectomy.
Spontaneous Coronary Artery Dissection in Patients with Autosomal Dominant Polycystic Kidney Disease: A Systematic Review of the Literature
Milutinovic, Stefan , Bell, Abraham, Jancic, Predrag , Stanojević, Dragana , Borghol, Abdul Hamid , Mina, Jonathan , Khambati, Ibrahim, Escárcega, Ricardo O. , Bell, Abraham, Chebib, Fouad T. , Wood, Malissa J.

Journal of Personalized Medicine | July 2, 2024 | Volume: 14 | Issue: 7 | Pages: 702

10.3390/jpm14070702 Get It

Spontaneous coronary artery dissection (SCAD) is a spontaneous intimal tear of the coronary artery wall. A factor rarely associated with SCAD is autosomal dominant polycystic kidney disease (ADPKD). Using the PRISMA guidelines, we identified 10 unique cases of SCAD in ADPKD patients reported between 1998 and 2021. Ages ranged from 36 to 59 years, with an average of 44.6 years. The majority of patients were female (80%). Each case was diagnosed with a cardiovascular event: ST-elevation myocardial infarction (STEMI) in 40%, non-ST elevation myocardial infarction (NSTEMI) in 50%, and stable angina in 10%. Conservative management was used in 60% of cases. There is a significant gap in our understanding of the relationship between SCAD and ADPKD. Polycystin complex can lead to structural abnormalities in blood vessels, resulting in vascular leaks and vessel rupture. This suggests that ADPKD patients may have an elevated risk of arteriopathies, including coronary artery dissection.